Harmony Biosciences Holdings, Inc.

HRMY · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$145$129$181$35
Dep. & Amort.$24$24$25$21
Deferred Tax-$29-$13$0$0
Stock-Based Comp.$43$32$27$16
Change in WC-$7$35-$7$2
Other Non-Cash$44$13-$82$25
Operating Cash Flow$220$219$144$99
Investing Activities
PP&E Inv.-$1-$0-$0-$0
Net Acquisitions-$33-$37$0$0
Inv. Purchases-$105-$127$0$0
Inv. Sales/Matur.$99$118$0$0
Other Inv. Act.-$27$0-$142-$100
Investing Cash Flow-$67-$46-$142-$100
Financing Activities
Debt Repay.-$15-$1-$2-$1
Stock Issued$7$0$0$0
Stock Repurch.$0-$100$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$2-$4$9$8
Financing Cash Flow-$11-$106$7$7
Forex Effect$0$0$0$0
Net Chg. in Cash$141$67$9$6
Supplemental Information
Beg. Cash$312$245$235$229
End Cash$453$312$245$235
Free Cash Flow$219$219$144$98
Harmony Biosciences Holdings, Inc. (HRMY) Financial Statements & Key Stats | AlphaPilot